A detailed history of Indiana Trust & Investment Management CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Indiana Trust & Investment Management CO holds 11,371 shares of ABBV stock, worth $2.02 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
11,371
Previous 11,416 0.39%
Holding current value
$2.02 Million
Previous $1.96 Million 14.66%
% of portfolio
0.77%
Previous 0.72%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$163.84 - $199.33 $7,372 - $8,969
-45 Reduced 0.39%
11,371 $2.25 Million
Q2 2024

Jul 10, 2024

SELL
$154.79 - $180.76 $32,041 - $37,417
-207 Reduced 1.78%
11,416 $1.96 Million
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $22,214 - $25,311
139 Added 1.21%
11,623 $2.12 Million
Q2 2023

Jul 07, 2023

SELL
$132.51 - $164.9 $11,130 - $13,851
-84 Reduced 0.73%
11,484 $1.55 Million
Q1 2023

Apr 06, 2023

SELL
$144.61 - $166.54 $71,437 - $82,270
-494 Reduced 4.1%
11,568 $1.84 Million
Q4 2022

Jan 09, 2023

BUY
$138.31 - $165.87 $1,244 - $1,492
9 Added 0.07%
12,062 $1.95 Million
Q3 2022

Oct 11, 2022

BUY
$134.21 - $153.93 $26,842 - $30,786
200 Added 1.69%
12,053 $1.62 Million
Q2 2022

Jul 08, 2022

SELL
$137.62 - $174.96 $27,524 - $34,992
-200 Reduced 1.66%
11,853 $1.82 Million
Q1 2022

Apr 04, 2022

SELL
$131.98 - $163.75 $8,974 - $11,135
-68 Reduced 0.56%
12,053 $1.95 Million
Q4 2021

Jan 10, 2022

BUY
$107.43 - $135.93 $7,412 - $9,379
69 Added 0.57%
12,121 $1.64 Million
Q3 2021

Oct 04, 2021

SELL
$106.4 - $120.78 $15,321 - $17,392
-144 Reduced 1.18%
12,052 $1.3 Million
Q2 2021

Jul 07, 2021

SELL
$105.21 - $117.21 $1,262 - $1,406
-12 Reduced 0.1%
12,196 $1.31 Million
Q1 2021

Apr 06, 2021

BUY
$102.3 - $112.62 $1,227 - $1,351
12 Added 0.1%
12,208 $1.32 Million
Q2 2020

Jul 14, 2020

BUY
$73.37 - $98.18 $5,062 - $6,774
69 Added 0.57%
12,196 $1.2 Million
Q1 2020

Apr 06, 2020

SELL
$64.5 - $97.79 $6,450 - $9,779
-100 Reduced 0.82%
12,127 $924,000
Q4 2019

Jan 13, 2020

SELL
$72.13 - $90.25 $129,545 - $162,089
-1,796 Reduced 12.81%
12,227 $1.08 Million
Q3 2019

Oct 04, 2019

SELL
$62.98 - $75.72 $46,731 - $56,184
-742 Reduced 5.03%
14,023 $1.06 Million
Q2 2019

Jul 10, 2019

SELL
$65.7 - $83.98 $143,883 - $183,916
-2,190 Reduced 12.92%
14,765 $1.07 Million
Q1 2019

Apr 08, 2019

SELL
$77.14 - $90.79 $61,557 - $72,450
-798 Reduced 4.5%
16,955 $1.37 Million
Q4 2018

Jan 07, 2019

SELL
$77.85 - $96.01 $6,617 - $8,160
-85 Reduced 0.48%
17,753 $1.64 Million
Q3 2018

Oct 11, 2018

SELL
$88.91 - $98.84 $35,564 - $39,536
-400 Reduced 2.19%
17,838 $1.69 Million
Q2 2018

Jul 06, 2018

SELL
$89.78 - $106.23 $107,287 - $126,944
-1,195 Reduced 6.15%
18,238 $1.69 Million
Q1 2018

Apr 09, 2018

BUY
$92.01 - $123.21 $124,305 - $166,456
1,351 Added 7.47%
19,433 $1.84 Million
Q4 2017

Jan 12, 2018

BUY
$89.56 - $98.21 $11,195 - $12,276
125 Added 0.7%
18,082 $1.75 Million
Q3 2017

Oct 05, 2017

BUY
$69.85 - $89.22 $1.25 Million - $1.6 Million
17,957
17,957 $1.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Indiana Trust & Investment Management CO Portfolio

Follow Indiana Trust & Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Indiana Trust & Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Indiana Trust & Investment Management CO with notifications on news.